← All trials
NCT01838447
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2013
- Primary completion
- Dec 1, 2015
- Completion date
- Dec 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 46
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of OttawaLead sponsor
- University of OttawaOverall official - principal investigator
- McGill UniversityStudy chair
- University of OttawaStudy chair
- McGill UniversityCollaborator
- Children's University Hospital, IrelandCollaborator
- University of OttawaCollaborator
- University of OttawaReponsible party - principal investigator
- National University of IrelandStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.